Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Biotech
Gilead bets $1.5B-plus on Merus' trispecifc T-cell engagers
Gilead is joining the likes of Amgen and Merck by heading deeper into the T-cell engager space.
Max Bayer
Mar 6, 2024 10:02am
Frontier CEO weathers one of his hardest fundraises to add $80M
Feb 22, 2024 4:01pm
GLP-1 enthusiasm pushes BioAge into new age with $170M series D
Feb 13, 2024 8:00am
Amgen's obesity drug may help patients keep the weight off
Feb 7, 2024 10:40am
Nvidia grows drug research footprint with Amgen, Recursion pacts
Jan 8, 2024 1:00pm
Jay Bradner returns to lead R&D at Amgen—Chutes & Ladders
Dec 15, 2023 9:30am